Biomarkers of disease activity in COPD and emphysema
The flaws of current methods of assessing disease severity in patients with COPD and emphysema are increasingly recognised, and new methods of assessing disease activity are urgently required. Although many potential biomarkers have been suggested to fulfil this role, few have been effectively valid...
Main Author: | |
---|---|
Published: |
University of Birmingham
2013
|
Subjects: | |
Online Access: | https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.569721 |